University of Patras
Αναστολή της πρωτεϊνικής σύνθεσης και της ρύθμισής της από παράγωγα φυσικών νουκλεοζιτών
Abstract
dc:descriptionThe race to combat the emerging multi-drug antimicrobial resistance that resulted from the mismanagement of antibiotic use in treatment of infectious diseases, has resulted in the stagnation of the antibiotic pipeline, while also leading to the abandonment of one of the most concerning medical fields of the 21st century. In light of the efforts to counteract this pressing development, one of the most preeminent approaches shies away from the discovery of novel compounds and instead redirects its efforts in repurposing classic “forgotten” antibiotics, that were prematurely dismissed in lieu of other more promising candidates. One of the most notable candidates is sparsomycin, a potent inhibitor of both prokaryotic and eukaryotic protein synthesis, initially studied for its antitumor potential. Sparsomycin had been shown to target the heart of the ribosome, the peptidyl transferase center (PTC), by binding near the P site and inhibiting the peptide bond formation, while also encroaching on the A site via its sulfur-containing tail. Despite the visualization of the sparsomycin binding site though, the exact mode of action remained elusive in terms of its PTase inhibitory activity.Based on a number of sparsomycin derivatives retained in our antibiotic drug bank, we decided to approach the study of sparsomycin and its derivatives albeit in a modern approach, utilizing functional and structural data along with next-generation sequencing (NGS) methods. The purpose of this study was to examine whether sparsomycin acts as a general inhibitor of protein synthesis as initially proposed, or as a context-specific inhibitor, promoting ribosomal stalling at specific locations during the translation of any given mRNA, whereby antibiotics act as modulators of gene expression rather than indiscriminately inhibiting the translation of all polypeptide chains. As a secondary objective, we strove to understand how modifications on the parental compound might affect the compound and whether it still retains the initial mode of action. To that end, we used time-dependent inhibition assays to determine the binding affinity of the modified sparsomycin derivatives along with other functional assays to determine the potency of our new compounds compared to sparsomycin. Additionally, we investigated their context-specificity with the toe-printing assay, a staple in translational stalling research, as well as the inverse toe-printing assay, a twist in the classic technique that harnesses the power of NGS to determine the effect of ribosomal stalling on a library of diverse mRNA transcripts. All of these functional assays were conducted in coordination with the structural analysis of our compounds using the T. thermophilus 70S ribosome, along with bound mRNA and A- P- site tRNAs.Our findings show that while sparsomycin acts as an inhibitor of translation elongation, it acts as a context-specific inhibitor, with ribosomes stalling downstream of the initiation codon. The structural data detail the rationale behind the compound’s mode of action thanks to high-resolution representations of the interactions between sparsomycin and the tRNA ligands in the PTC. Furthermore, the inverse toe-printing assay shows amino acid enrichments in the stalling sites that help elucidate the exact mechanism of sparsomycin inhibition of protein synthesis. In parallel, the sparsomycin derivatives are proven to be more potent than the parental compound yet display differences in translational stalling and binding site interactions, demonstrating the important effect of modifications on the antibiotic mode of action. Understanding the distinction between general and context-specific mode of inhibition will initiate a more holistic approach on the assessment of antibiotics in general, while also providing novel insights on derivatization strategies of old and novel inhibitors that target the ribosome.
Degree
thesis:*- Grantor dc:publisher
- University of Patras
- Year dc:date
- 2021
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Bougas, Antonios
- Μπουγάς, Αντώνιος
Subjects
dc:subject × 10Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/51151